US Patent Issued to Fred Hutchinson Cancer Center, Memorial Sloan-Kettering Cancer Center on May 13 for "Luteinizing hormone receptor binding agents and luteinizing hormone agonists to identify, expand, ablate and modify stem cells" (Washington, New York Inventors)

ALEXANDRIA, Va., June 12 -- United States Patent no. 12,295,973, issued on May 13, was assigned to Fred Hutchinson Cancer Center (Seattle) and Memorial Sloan-Kettering Cancer Center (New York).

"Luteinizing hormone receptor binding agents and luteinizing hormone agonists to identify, expand, ablate and modify stem cells" was invented by Jarrod Dudakov (Seattle), Marcel van den Brink (New York), Enrico Velardi (New York), Hans-Peter Kiem (Seattle), Stefan Radtke (Seattle) and Scott James (New York).

According to the abstract* released by the U.S. Patent & Trademark Office: "The use of luteinizing hormone receptor (LHR) binding agents and luteinizing hormone (LH) agonists to enrich for primitive hematopoietic stem cell (pHSC) populations, t...